Loading...

Allegra Orthopaedics

ASX:AMT
Snowflake Description

Flawless balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AMT
ASX
A$9M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia. The last earnings update was 117 days ago. More info.


Add to Portfolio Compare Print
  • Allegra Orthopaedics has significant price volatility in the past 3 months.
AMT Share Price and Events
7 Day Returns
13.9%
ASX:AMT
2.2%
AU Medical Equipment
1.7%
AU Market
1 Year Returns
-30.8%
ASX:AMT
7.4%
AU Medical Equipment
5.4%
AU Market
AMT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Allegra Orthopaedics (AMT) 13.9% -10% -25% -30.8% -40% 50%
AU Medical Equipment 2.2% 1.5% 11.5% 7.4% 54.3% 119%
AU Market 1.7% 2.8% 5.5% 5.4% 25% 12.3%
1 Year Return vs Industry and Market
  • AMT underperformed the Medical Equipment industry which returned 7.4% over the past year.
  • AMT underperformed the Market in Australia which returned 5.4% over the past year.
Price Volatility
AMT
Industry
5yr Volatility vs Market

AMT Value

 Is Allegra Orthopaedics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Allegra Orthopaedics. This is due to cash flow or dividend data being unavailable. The share price is A$0.09.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Allegra Orthopaedics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Allegra Orthopaedics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:AMT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$-0.01
ASX:AMT Share Price ** ASX (2019-06-13) in AUD A$0.09
Australia Medical Equipment Industry PE Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 36.61x
Australia Market PE Ratio Median Figure of 545 Publicly-Listed Companies 16.2x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Allegra Orthopaedics.

ASX:AMT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:AMT Share Price ÷ EPS (both in AUD)

= 0.09 ÷ -0.01

-10.09x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allegra Orthopaedics is loss making, we can't compare its value to the AU Medical Equipment industry average.
  • Allegra Orthopaedics is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does Allegra Orthopaedics's expected growth come at a high price?
Raw Data
ASX:AMT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -10.09x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Oceania Medical Equipment Industry PEG Ratio Median Figure of 5 Publicly-Listed Medical Equipment Companies 2.88x
Australia Market PEG Ratio Median Figure of 357 Publicly-Listed Companies 1.4x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Allegra Orthopaedics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Allegra Orthopaedics's assets?
Raw Data
ASX:AMT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$0.06
ASX:AMT Share Price * ASX (2019-06-13) in AUD A$0.09
Australia Medical Equipment Industry PB Ratio Median Figure of 30 Publicly-Listed Medical Equipment Companies 2.16x
Australia Market PB Ratio Median Figure of 1,687 Publicly-Listed Companies 1.65x
ASX:AMT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:AMT Share Price ÷ Book Value per Share (both in AUD)

= 0.09 ÷ 0.06

1.49x

* Primary Listing of Allegra Orthopaedics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allegra Orthopaedics is good value based on assets compared to the AU Medical Equipment industry average.
X
Value checks
We assess Allegra Orthopaedics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Allegra Orthopaedics has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AMT Future Performance

 How is Allegra Orthopaedics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
16.8%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Allegra Orthopaedics expected to grow at an attractive rate?
  • Unable to compare Allegra Orthopaedics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Allegra Orthopaedics's earnings growth to the Australia market average as no estimate data is available.
  • Unable to compare Allegra Orthopaedics's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:AMT Future Growth Rates Data Sources
Data Point Source Value (per year)
Australia Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 16.8%
Australia Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 10.4%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.9%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:AMT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:AMT Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
ASX:AMT Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 5 -1 -1
2018-09-30 5 -1 -1
2018-06-30 5 -2 -1
2018-03-31 5 -1 0
2017-12-31 6 -1 0
2017-09-30 6 -1 0
2017-06-30 6 0 1
2017-03-31 6 0 0
2016-12-31 6 0 -1
2016-09-30 6 -1 -1
2016-06-30 6 -1 -2
2016-03-31 7 0 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Allegra Orthopaedics is high growth as no earnings estimate data is available.
  • Unable to determine if Allegra Orthopaedics is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:AMT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Allegra Orthopaedics Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:AMT Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
ASX:AMT Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.01
2018-03-31 0.00
2017-12-31 0.00
2017-09-30 0.00
2017-06-30 0.01
2017-03-31 0.00
2016-12-31 -0.01
2016-09-30 -0.02
2016-06-30 -0.03
2016-03-31 -0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Allegra Orthopaedics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Allegra Orthopaedics's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Allegra Orthopaedics's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Allegra Orthopaedics's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Allegra Orthopaedics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Allegra Orthopaedics has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AMT Past Performance

  How has Allegra Orthopaedics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Allegra Orthopaedics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Allegra Orthopaedics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Allegra Orthopaedics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Allegra Orthopaedics's 1-year growth to the AU Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Allegra Orthopaedics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Allegra Orthopaedics Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:AMT Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 5.02 -0.89 2.98 1.44
2018-09-30 5.13 -0.75 3.09 1.34
2018-06-30 5.24 -0.60 3.20 1.23
2018-03-31 5.45 -0.24 3.12 1.19
2017-12-31 5.66 0.12 2.99 1.12
2017-09-30 5.84 0.31 2.97 1.01
2017-06-30 6.02 0.50 2.94 0.90
2017-03-31 5.79 -0.10 3.40 0.88
2016-12-31 5.57 -0.71 3.85 0.85
2016-09-30 5.78 -1.37 4.00 1.10
2016-06-30 5.99 -2.04 4.15 1.34
2016-03-31 6.64 -1.89 4.20 1.51
2015-12-31 7.29 -1.74 4.26 1.67
2015-09-30 7.91 -1.30 4.33 1.63
2015-06-30 8.53 -0.86 4.39 1.58
2015-03-31 8.73 -0.55 4.15 1.50
2014-12-31 8.92 -0.24 3.90 1.41
2014-09-30 8.85 -0.27 4.06 1.40
2014-06-30 8.79 -0.30 4.21 1.39
2014-03-31 8.60 -0.51 4.16 1.34
2013-12-31 8.40 -0.72 4.12 1.28
2013-09-30 8.06 -0.61 3.86 1.21
2013-06-30 7.72 -0.49 3.60 1.15
2012-12-31 8.61 0.29 3.35 1.13
2012-09-30 8.67 0.04 3.47 1.21
2012-06-30 8.72 -0.21 3.58 1.30

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Allegra Orthopaedics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Allegra Orthopaedics has efficiently used its assets last year compared to the AU Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Allegra Orthopaedics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Allegra Orthopaedics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Allegra Orthopaedics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AMT Health

 How is Allegra Orthopaedics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Allegra Orthopaedics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Allegra Orthopaedics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Allegra Orthopaedics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Allegra Orthopaedics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Allegra Orthopaedics has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Allegra Orthopaedics Company Filings, last reported 5 months ago.

ASX:AMT Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 6.01 0.00 1.18
2018-09-30 6.01 0.00 1.18
2018-06-30 6.48 0.00 1.61
2018-03-31 6.48 0.00 1.61
2017-12-31 6.90 0.02 2.25
2017-09-30 6.90 0.02 2.25
2017-06-30 4.56 0.15 1.85
2017-03-31 4.56 0.15 1.85
2016-12-31 3.07 0.07 1.08
2016-09-30 3.07 0.07 1.08
2016-06-30 2.15 1.12 1.15
2016-03-31 2.15 1.12 1.15
2015-12-31 3.05 0.17 0.83
2015-09-30 3.05 0.17 0.83
2015-06-30 4.19 0.32 1.08
2015-03-31 4.19 0.32 1.08
2014-12-31 4.78 0.54 1.24
2014-09-30 4.78 0.54 1.24
2014-06-30 4.17 1.80 0.03
2014-03-31 4.17 1.80 0.03
2013-12-31 4.13 1.72 0.09
2013-09-30 4.13 1.72 0.09
2013-06-30 4.20 1.88 0.29
2012-12-31 3.71 2.40 0.02
2012-09-30 3.71 2.40 0.02
2012-06-30 4.04 2.59 0.00
  • Allegra Orthopaedics has no debt.
  • Allegra Orthopaedics has no debt compared to 5 years ago when it was 41.7%.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Allegra Orthopaedics has sufficient cash runway for 1.1 years based on current free cash flow.
  • Allegra Orthopaedics has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 49.1% each year.
X
Financial health checks
We assess Allegra Orthopaedics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Allegra Orthopaedics has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AMT Dividends

 What is Allegra Orthopaedics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Allegra Orthopaedics dividends.
If you bought A$2,000 of Allegra Orthopaedics shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Allegra Orthopaedics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Allegra Orthopaedics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:AMT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Oceania Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.7%
Australia Market Average Dividend Yield Market Cap Weighted Average of 415 Stocks 4.1%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.7%
Australia Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:AMT Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Allegra Orthopaedics has not reported any payouts.
  • Unable to verify if Allegra Orthopaedics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Allegra Orthopaedics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Allegra Orthopaedics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Allegra Orthopaedics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Allegra Orthopaedics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Allegra Orthopaedics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AMT Management

 What is the CEO of Allegra Orthopaedics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jenny Swain
COMPENSATION A$363,859
TENURE AS CEO 3.1 years
CEO Bio

Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its National Sales Manager. She has over 15 years experience in orthopaedic sales and support. Prior to moving into a sales function, she spent 12 years as a formally trained and qualified Registered Nurse with practical experience in local and overseas hospitals. This included 5 years in Los Angeles Century City Hospital as orthopaedic Unit Manager. She joined J&J in 1996 at NSW Orthopaedic Territory Manager and in February, 2000 joined Taylor Bryant now Lifehealthcare as Divisional Manager for Orthopaedic Division. She has worked on a national level with orthopaedic surgeons specialising in small and large joints and has strong relationships not only domestically but internationally.

CEO Compensation
  • Jenny's compensation has increased whilst company is loss making.
  • Jenny's remuneration is about average for companies of similar size in Australia.
Management Team Tenure

Average tenure of the Allegra Orthopaedics management team in years:

2.4
Average Tenure
  • The tenure for the Allegra Orthopaedics management team is about average.
Management Team

Jenny Swain

TITLE
Chief Executive Officer
COMPENSATION
A$364K
TENURE
3.1 yrs

Justyn Stedwell

TITLE
Company Secretary
TENURE
2.4 yrs

Chris Calamos

TITLE
Commercial & Finance Manager
COMPENSATION
A$129K
TENURE
2.4 yrs
Board of Directors Tenure

Average tenure and age of the Allegra Orthopaedics board of directors in years:

3.6
Average Tenure
65
Average Age
  • The tenure for the Allegra Orthopaedics board of directors is about average.
Board of Directors

Peter Kazacos

TITLE
Non-Executive Chairman
COMPENSATION
A$63K
AGE
65
TENURE
3.7 yrs

Tony Hartnell

TITLE
Non-Executive Director
COMPENSATION
A$33K
AGE
77
TENURE
4.6 yrs

Sean St Mulhearn

TITLE
Non-Executive Director
COMPENSATION
A$33K
AGE
56
TENURE
3.6 yrs

Nicholas Hartnell

TITLE
Non-Executive Director
COMPENSATION
A$15K
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
X
Management checks
We assess Allegra Orthopaedics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Allegra Orthopaedics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AMT News

Simply Wall St News

Is Allegra Orthopaedics Limited's (ASX:AMT) CEO Paid At A Competitive Rate?

See our latest analysis for Allegra Orthopaedics How Does Jenny Swain's Compensation Compare With Similar Sized Companies? … According to our data, Allegra Orthopaedics Limited has a market capitalization of AU$7.9m, and pays its CEO total annual compensation worth AU$364k. … ASX:AMT CEO Compensation, June 12th 2019 Is Allegra Orthopaedics Limited Growing?

Simply Wall St -

Is Allegra Orthopaedics's Share Price Gain Of 133% Well Earned?

One great example is Allegra Orthopaedics Limited (ASX:AMT) which saw its share price drive 133% higher over five years. … Given that Allegra Orthopaedics didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. … When a company doesn't yet make profits, we'd generally expect to see good revenue growth.

Simply Wall St -

Are Allegra Orthopaedics Limited's (ASX:AMT) Interest Costs Too High?

The direct benefit for Allegra Orthopaedics Limited (ASX:AMT), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is financial flexibility worth the lower cost of capital. … There are well-known benefits of including debt in capital structure, primarily a lower cost of capital

Simply Wall St -

Who Owns Allegra Orthopaedics Limited (ASX:AMT)?

I am going to take a deep dive into Allegra Orthopaedics Limited’s (ASX:AMT) most recent ownership structure, not a frequent subject of discussion among individual investors. … The impact of a company's ownership structure affects both its short- and long-term performance. … Therefore, it is beneficial for us to examine AMT's ownership structure in more detail.

Simply Wall St -

Should You Sell Allegra Orthopaedics Limited (ASX:AMT) At This PE Ratio?

and want to better understand how you can grow your money by investing in Allegra Orthopaedics Limited (ASX:AMT). … Allegra Orthopaedics Limited (ASX:AMT) is currently trading at a trailing P/E of 87.4x, which is higher than the industry average of 49.2x. … While this makes AMT appear like a stock to avoid or sell if you own it, you might change your mind after I explain the assumptions behind the P/E ratio

Simply Wall St -

What Investors Should Know About Allegra Orthopaedics Limited's (ASX:AMT) Financial Strength

Last year, AMT’s operating cash flow was 0.99x its current debt. … AMT has demonstrated its ability to generate sufficient levels of cash flow, while its debt hovers at a safe level. … AMT’s high cash coverage and low levels of debt indicate its ability to use its borrowings efficiently in order to produce a healthy cash flow.

Simply Wall St -

AMT Company Info

Description

Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems, knee distal first instruments, and screws, as well as femoral condyle, PF wave, and nanofracture technology products. The company also provides foot and ankle products, such as total ankle replacement systems, toe products, A-curve handles, screws, and staples; surgical screws, sawblades, and kirschner wires; and microfracture handles. In addition, it offers consulting services. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was founded in 1994 and is based in Lane Cove West, Australia.

Details
Name: Allegra Orthopaedics Limited
AMT
Exchange: ASX
Founded: 1994
A$8,960,314
99,559,052
Website: http://www.allegraorthopaedics.com
Address: Allegra Orthopaedics Limited
18-20 Orion Road,
Level 8,
Lane Cove West,
New South Wales, 2066,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX AMT Ordinary Shares Australian Securities Exchange AU AUD 05. Dec 2007
Number of employees
Current staff
Staff numbers
0
Allegra Orthopaedics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/17 10:37
End of day share price update: 2019/06/13 00:00
Last estimates confirmation: 2018/08/23
Last earnings filing: 2019/02/20
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.